Literature DB >> 8882639

Subtle determinants of the nucleocytoplasmic partitioning of in vivo-transcribed RNase MRP RNA in Xenopus laevis oocytes.

S Jeong-Yu1, A F Davis, D A Clayton.   

Abstract

RNase MRP is a ribonucleoprotein originally identified on the basis of its ability to cleave RNA endonucleolytically from origins of mitochondrial DNA replication, rendering it a likely candidate for a role in priming leading-strand synthesis of mtDNA. In addition, a nuclear role for RNase MRP has been identified in yeast (Saccharomyces cerevisiae) ribosomal RNA processing. Consistent with a duality of function, RNase MRP has been localized to both mitochondria and nucleoli by in situ techniques. The RNA component of this ribonucleoprotein has been characterized from several different species. We previously cloned the gene for Xenopus laevis MRP RNA and showed that RNase MRP RNA is differentially expressed during amphibian development; in addition, the microinjected X. laevis RNase MRP RNA gene is correctly and efficiently transcribed in vivo. This article presents an analysis of the intracellular movement of in vivo-transcribed RNase MRP RNA in microinjected mature X. laevis oocytes. Although X. laevis MRP RNA is assembled into a ribonucleoprotein form and transported in an expected manner, human and mouse MRP RNAs exhibit markedly different transport patterns even though they are highly conserved in primary sequence. Furthermore, the only currently assigned protein (Th autoantigen) binding site in MRP RNA can be deleted without loss of nuclear export capacity. These results indicate that subtle determinants must exist for nucleocytoplasmic partitioning of this RNP and that the conserved Th autoantigen binding region appears unnecessary for the transit of in vivo-transcribed MRP RNA to the cytoplasm of mature X. laevis oocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882639      PMCID: PMC6138017     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  42 in total

1.  Secondary structure of the RNA component of a nuclear/mitochondrial ribonucleoprotein.

Authors:  J N Topper; D A Clayton
Journal:  J Biol Chem       Date:  1990-08-05       Impact factor: 5.157

Review 2.  Nuclear import-export: in search of signals and mechanisms.

Authors:  E A Nigg; P A Baeuerle; R Lührmann
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

3.  Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals.

Authors:  J N Dumont
Journal:  J Morphol       Date:  1972-02       Impact factor: 1.804

4.  Depletion of U14 small nuclear RNA (snR128) disrupts production of 18S rRNA in Saccharomyces cerevisiae.

Authors:  H D Li; J Zagorski; M J Fournier
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

5.  Retention and 5' cap trimethylation of U3 snRNA in the nucleus.

Authors:  M P Terns; J E Dahlberg
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

6.  The RNA processing enzyme RNase MRP is identical to the Th RNP and related to RNase P.

Authors:  H A Gold; J N Topper; D A Clayton; J Craft
Journal:  Science       Date:  1989-09-22       Impact factor: 47.728

7.  A novel transcriptional activator (PO-B) binds between the TATA box and cap site of the pro-opiomelanocortin gene.

Authors:  A T Riegel; J Remenick; R G Wolford; D S Berard; G L Hager
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

8.  5' flanking sequences of human MRP/7-2 RNA gene are required and sufficient for the transcription by RNA polymerase III.

Authors:  Y Yuan; R Reddy
Journal:  Biochim Biophys Acta       Date:  1991-05-02

9.  The RNA of RNase MRP is required for normal processing of ribosomal RNA.

Authors:  S Chu; R H Archer; J M Zengel; L Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

10.  Translocation of RNA-coated gold particles through the nuclear pores of oocytes.

Authors:  S I Dworetzky; C M Feldherr
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.